Gilad Kunis

1.5k total citations
15 papers, 1.2k citations indexed

About

Gilad Kunis is a scholar working on Neurology, Physiology and Neurology. According to data from OpenAlex, Gilad Kunis has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 5 papers in Physiology and 4 papers in Neurology. Recurrent topics in Gilad Kunis's work include Neuroinflammation and Neurodegeneration Mechanisms (12 papers), Alzheimer's disease research and treatments (4 papers) and Immune cells in cancer (3 papers). Gilad Kunis is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (12 papers), Alzheimer's disease research and treatments (4 papers) and Immune cells in cancer (3 papers). Gilad Kunis collaborates with scholars based in Israel, United States and Italy. Gilad Kunis's co-authors include Michal Schwartz, Oleg Butovsky, Maya Koronyo‐Hamaoui, Eran Ophir, Gennady Landa, Hagit Cohen, Omer Miller, Kuti Baruch, Tamara Berkutzki and Neta Rosenzweig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Gilad Kunis

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilad Kunis Israel	11	861	450	332	242	193	15	1.2k
Neta Rosenzweig Israel	6	1.1k 1.3×	547 1.2×	516 1.6×	451 1.9×	230 1.2×	8	1.7k
DeRen Huang United States	8	1.0k 1.2×	219 0.5×	609 1.8×	130 0.5×	226 1.2×	8	1.6k
Taitea Dykstra United States	11	564 0.7×	186 0.4×	254 0.8×	141 0.6×	270 1.4×	12	1.1k
Bernice Matusow United States	5	1.2k 1.4×	230 0.5×	584 1.8×	163 0.7×	226 1.2×	13	1.4k
Kathleen Grabert Sweden	10	918 1.1×	233 0.5×	510 1.5×	142 0.6×	167 0.9×	16	1.2k
Connor Dufort United States	4	1.1k 1.3×	194 0.4×	652 2.0×	143 0.6×	166 0.9×	4	1.4k
Zain Fanek United States	3	1.7k 2.0×	381 0.8×	1.0k 3.1×	196 0.8×	228 1.2×	6	2.2k
Frederick W. Gergits United States	5	1.2k 1.3×	202 0.4×	653 2.0×	145 0.6×	201 1.0×	6	1.4k
Mark R. Mizee Netherlands	13	773 0.9×	230 0.5×	329 1.0×	89 0.4×	170 0.9×	17	1.3k
Anna Michel Germany	9	717 0.8×	153 0.3×	443 1.3×	82 0.3×	142 0.7×	30	1.1k

Countries citing papers authored by Gilad Kunis

Since Specialization

Citations

This map shows the geographic impact of Gilad Kunis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad Kunis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad Kunis more than expected).

Fields of papers citing papers by Gilad Kunis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilad Kunis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad Kunis. The network helps show where Gilad Kunis may publish in the future.

Co-authorship network of co-authors of Gilad Kunis

This figure shows the co-authorship network connecting the top 25 collaborators of Gilad Kunis. A scholar is included among the top collaborators of Gilad Kunis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilad Kunis. Gilad Kunis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Papait, Andrea, Anna Cargnoni, Antonietta Rosa Silini, et al.. (2021). Perinatal Cells: A Promising COVID-19 Therapy?. Frontiers in Bioengineering and Biotechnology. 8. 619980–619980. 5 indexed citations

Paul, Amber M., Gilad Kunis, Racheli Ofir, et al.. (2021). Placenta-Expanded Stromal Cell Therapy in a Rodent Model of Simulated Weightlessness. Cells. 10(4). 940–940. 6 indexed citations

Kunis, Gilad, Kuti Baruch, Omer Miller, & Michal Schwartz. (2015). Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS. Journal of Neuroscience. 35(16). 6381–6393. 81 indexed citations

Kunis, Gilad, Kuti Baruch, Neta Rosenzweig, et al.. (2013). IFN-γ-dependent activation of the brain’s choroid plexus for CNS immune surveillance and repair. Brain. 136(11). 3427–3440. 242 indexed citations

Finkelstein, Arseny, Gilad Kunis, Tamara Berkutzki, et al.. (2011). Immunomodulation by poly-YE reduces organophosphate-induced brain damage. Brain Behavior and Immunity. 26(1). 159–169. 10 indexed citations

Vaknin, Ilan, Gilad Kunis, Omer Miller, et al.. (2011). Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis. PLoS ONE. 6(11). e26921–e26921. 53 indexed citations

Finkelstein, Arseny, Gilad Kunis, Akop Seksenyan, et al.. (2011). Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS. PLoS ONE. 6(8). e22374–e22374. 65 indexed citations

Koronyo‐Hamaoui, Maya, MinHee K. Ko, Yosef Koronyo, et al.. (2009). Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9. Journal of Neurochemistry. 111(6). 1409–1424. 93 indexed citations

Koronyo‐Hamaoui, Maya, MinHee K. Ko, Yosef Koronyo, et al.. (2009). Koronyo-Hamaoui, M. et al. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J. Neurochem. 111, 1409-1424. 5 indexed citations

10.

Koronyo‐Hamaoui, Maya, MinHee K. Ko, David Azoulay, et al.. (2009). P2‐232: Immune‐based therapy for Alzheimer's disease is associated with elevated levels of IL‐10 in the brain. Alzheimer s & Dementia. 5(4S_Part_11). 5 indexed citations

11.

Schwartz, Michal, et al.. (2008). Application of Glatiramer Acetate to Neurodegenerative Diseases beyond Multiple Sclerosis. BioDrugs. 22(5). 293–299. 12 indexed citations

12.

Butovsky, Oleg, et al.. (2007). Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers. Molecular and Cellular Neuroscience. 35(3). 490–500. 66 indexed citations

13.

Butovsky, Oleg, Gilad Kunis, Maya Koronyo‐Hamaoui, & Michal Schwartz. (2007). Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. European Journal of Neuroscience. 26(2). 413–416. 137 indexed citations

14.

Butovsky, Oleg, Maya Koronyo‐Hamaoui, Gilad Kunis, et al.. (2006). Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proceedings of the National Academy of Sciences. 103(31). 11784–11789. 315 indexed citations

15.

Butovsky, Oleg, Maya Koronyo‐Hamaoui, Gilad Kunis, et al.. (2006). Butovsky, O. et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 11784-11789. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact